XML 12 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
IMPAIRMENTS
9 Months Ended
Sep. 30, 2013
IMPAIRMENTS [Abstract]  
IMPAIRMENTS
Note 11:          IMPAIRMENTS

Health nad Beauty Operations:
 
During the third quarter of 2013, we committed to divest our health and beauty (HBS) operations within our performance materials segment and adjusted the carrying value of HBS's net assets held-for-sale to their $12.0 fair value less cost to sell (see Note 12 for further details). The fair value adjustment  resulted in impairment charges of $1.8, $1.1, and $1.3; relating to HBS's goodwill, intangible assets, and property, plant and equipment, respectively.

As required by ASC Topic 350 - Intangibles - Goodwill and Other, we completed an interim test for goodwill and intangible assets for HBS's operations during the third quarter of 2013. In the first step of the goodwill impairment evaluation, we compared the fair value of HBS based on an observable Level 2 fair value input with its carrying amount, which suggested the goodwill was impaired.  In performing the second step of impairment test, we determined that the implied fair value of goodwill was lower than carrying amount, and recorded an impairment loss of $1.8.

The $1.1 impairment charge for intangible assets relates to trademarks and developed technology, and was assessed using the relief from royalty rate method (Level 3 fair value input). Critical assumptions used in conducting these tests included applicable market royalty rates and discount rates as well as the future performance of these assets.  

The $1.3 impairment charge relating to HBS's plant, property and equipment was assessed using cost method adjusted for age and deterioration (Level 3 fair value input).

South Africa:

               During the quarter ended September 30, 2013, our performance materials segment recorded an impairment charge of $52.3 to record a write down of mineral rights ($36.0) and depreciable assets ($16.3) from their carrying value to their estimated fair values.  Fair value for mineral rights was assessed using discounted cash flow approach (Level 3 fair value input) and for depreciable assets using a combination of mass appraisal technique and market approach technique (Level 2 fair value input).  The impairment charge relates to a significant adverse change in the business climate experienced by our South African chromite operations.  Specifically, recently developed overcapacity in the supply of chromite has impacted our pricing and ability to grow market share in the foundry grade market which required us to perform a review of recoverability in the third quarter of 2013.  Based on that evaluation, we determined the long-lived assets that produce chromite were not recoverable on a gross cash flow analysis. The impairment charge is recorded within our condensed consolidated statements of operations within cost of sales ($52.2) and selling, general and administrative expense ($0.1).